Home » Topics » BioWorld Science

BioWorld Science
RSS

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Cel-Sci's Multikine to be tested clinically at additional centers

Sep. 27, 1996

Prostate cancer treatment approved by the FDA

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Joint venture to develop Biopharmaceutics' orphan anticancer drug

Sep. 27, 1996

Promising phase II results with vaccine for staph infections

Sep. 27, 1996

Clinical trial of an oral Campylobacter vaccine and adjuvant combination

Sep. 27, 1996

Immunosuppressant oligopeptide from Italfarmaco

Sep. 27, 1996

Kureha glycoproteins show antitumor and immunomodulatory effects

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026